Cracking the Code of Life: An Interview with Stef van Grieken, CEO of Cradle, on AI-Driven Protein Engineering

The integration of artificial intelligence (AI) in biotech is not just enhancing the efficiency of processes but is also enabling …

Continue ›››

Xaira Therapeutics Launches with Over $1 Billion to Enhance Drug R&D Using AI

As first reported by Endpoints News, Xaira Therapeutics has emerged as one of the most significantly funded new entrants in …

Continue ›››

Rubedo Garners $40M to Advance Clinical Trials in Age-Related Diseases

Rubedo Life Sciences, a biopharmaceutical company specializing in the development of therapies targeting senescent cells associated with age-related diseases, has …

Continue ›››

A Landscape of AI-discovered Molecules and Target Novelty Analysis

We have recently launched a report, “It’s Been a Decade of AI in the Drug Discovery Race. What’s Next?” where …

Continue ›››

Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials

In an industry as critical as clinical trials, where efficient data management and swift processes are paramount, outdated tech methods …

Continue ›››

How Industry Embraces Organ-on-Chips: A 2024 Status Report

Report highlights: We are currently at an exciting juncture where several big pharmaceutical companies have started adopting such models and …

Continue ›››

Healthcare Industry Faces Cybersecurity Mismatch, According to Kroll's Latest Report

Kroll, a global leader in risk and financial advisory solutions, has unveiled findings from its recent "State of Cyber Defense: …

Continue ›››

Isospec Analytics Secures $1.9 Million to Advance Biomolecular Identification Technology

Any given human blood sample has 15,000 small biological molecules that can give precise information about a person’s health at …

Continue ›››

Seed Health Unveils CODA: Pioneering Computational Biology Platform for Microbiome Research

Seed Health has announced the launch of CODA, a cutting-edge computational biology platform that utilizes the extensive data from the …

Continue ›››

A Closer Look at Elsevier's AI Strategy in Drug Discovery

My interview with Mirit Eldor, Managing Director, Life Sciences Solutions, at Elsevier, as we discuss Elsevier's recent collaboration with gen …

Continue ›››

11 Notable Companies Enabling Decentralized Clinical Trials

The world of clinical trials is undergoing an evolution as the rise of decentralized clinical trials (DCTs) brings about a change …

Continue ›››

How AI Empowers Biomarker-Driven Clinical Trials

Clinical trials are the lifeline of modern medicine, bridging the gap between lab-borne scientific discoveries and the availability of life-saving …

Continue ›››